SEC Filings - Bolt Biotherapeutics

Filing date	Description	Form	Filing Group	View
March 28, 2022	Statement of changes in beneficial ownership of securities	4	3,4,5	0000899243-22-012466.pdf 0000899243-22-012466.rtf 0000899243-22-012466.xls View HTML
March 4, 2022	Report of unscheduled material events or corporate event	8-K	Current Reports	0000950170-22-002873.pdf 0000950170-22-002873.rtf 0000950170-22-002873.xls EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT View HTML
February 23, 2022	Statement of changes in beneficial ownership of securities	4	3,4,5	0000899243-22-007524.pdf 0000899243-22-007524.rtf 0000899243-22-007524.xls View HTML
February 23, 2022	Statement of changes in beneficial ownership of securities	4	3,4,5	0000899243-22-007526.pdf 0000899243-22-007526.rtf 0000899243-22-007526.xls View HTML
February 23, 2022	Statement of changes in beneficial ownership of securities	4	3,4,5	0000899243-22-007519.pdf 0000899243-22-007519.rtf 0000899243-22-007519.xls View HTML
February 23, 2022	Statement of changes in beneficial ownership of securities	4	3,4,5	0000899243-22-007520.pdf 0000899243-22-007520.rtf 0000899243-22-007520.xls View HTML
February 23, 2022	Statement of changes in beneficial ownership of securities	4	3,4,5	0000899243-22-007525.pdf 0000899243-22-007525.rtf 0000899243-22-007525.xls View HTML
February 14, 2022	An amendment to the SC 13G filing	SC 13G/A	Other	0001104659-22-021146.pdf 0001104659-22-021146.rtf 0001104659-22-021146.xls View HTML
February 1, 2022	Statement of changes in beneficial ownership of securities	4	3,4,5	0000899243-22-003917.pdf 0000899243-22-003917.rtf 0000899243-22-003917.xls View HTML
January 25, 2022	Report of unscheduled material events or corporate event	8-K	Current Reports	0001564590-22-002321.pdf 0001564590-22-002321.rtf 0001564590-22-002321.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.